LifeStance Health Group

Lifestance Health Group, Inc. provides outpatient mental health services. It offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. The firm operates outpatient mental health platform as well as offers patients care virtually through its online delivery platform or in-person at its centers in 32 states. The company was founded by Michael K. Lester, Gwen H. Booth and Danish J. Qureshi in 2017 and is headquartered in Scottsdale, AZ.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

LifeStance Health Group reports strong Q4 performance and outlines growth strategies for 2023

LifeStance Health Group's Q4 2022 performance reflects financial stability and operational strength, meeting expectations.
The company's strategic focus on long-term profitability, clinician growth, and value-based care positions it for future success.
Challenges include consolidation efforts, payer contracting complexities, and transitioning to an integrated care model.
Opportunities for growth lie in collaboration with physical care providers, value-based care models, and data-driven approaches.

LifeStance Health Group exceeds Q1 expectations, eyes sustainable growth

LifeStance Health Group's Q1 2023 performance showcased strong financial results and operational advancements, driven by clinician growth and strategic initiatives.
While facing challenges such as clinician recruitment and margin progression, the company's focus on retention and value-based care initiatives bodes well for future growth.
With opportunities in clinician expansion, operational enhancements, and market adaptation, LifeStance Health Group is poised to capitalize on emerging trends and drive sustainable success.

LifeStance Health Group excels in Q2, eyes growth opportunities

LifeStance Health Group's Q2 2023 earnings call highlighted strong financial performance, operational improvements, and a strategic focus on enhancing patient care and value-based care arrangements. The company is navigating challenges in streamlining operations and adapting to regulatory changes while capitalizing on opportunities to drive growth and operational efficiencies.

LifeStance Health Group exceeds Q3 expectations, focuses on growth

LifeStance Health Group's Q3 2023 performance reflects strong revenue growth, operational improvements, and a focus on patient and clinician satisfaction.
While facing challenges such as negative free cash flow and ongoing legal actions, the company is poised for growth through revenue guidance increases and strategic investments.
Opportunities for revenue growth, clinician expansion, and enhanced patient experiences align with the company's commitment to quality care and financial performance.
CEO Ken Burdick's emphasis on exceeding expectations, raising guidance, and navigating legal challenges underscores the company's resilience and strategic direction.

LifeStance Health Group beats 2023 metrics, focuses on growth optimization

LifeStance Health Group's strong financial performance in 2023 reflects a focus on profitability, clinician growth, and patient experience, with plans for continued optimization.
Strategic investments in technology and operational processes position the company for future success, while challenges in moderating growth and improving funnel efficiency require attention.
Opportunities lie in enhancing patient acquisition and retention, clinician productivity, and operational efficiency, leveraging the company's early growth stage for scalability.
Management's commitment to a purpose-driven culture and operational excellence, supported by a dedicated team, underpins LifeStance Health Group's path to sustained success.

LifeStance Health Group excels in Q1 2024, eyes growth opportunities

LifeStance Health Group's Q1 2024 Earnings Call showcased robust financial performance, strategic resilience, and a focus on growth. While facing leadership transitions and short-term challenges, the company is poised for positive cash flow and continued improvements in revenue and margins.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

New York, New York--(Newsfile Corp. - August 13, 2022) - WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of LifeStance Health Group, Inc. (NASDAQ: LFST) pursuant and/or traceable to the registration statement and related prospectus (collectively, the "Registration Statement") issued in connection with LifeStance Health's June 2021 initial public offering (the "IPO").

ROSEN, A LONGSTANDING AND TRUSTED FIRM, Encourages LifeStance Health Group, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - LFST

SAN DIEGO , Aug. 12, 2022 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that it has filed a class action lawsuit seeking to represent purchasers of LifeStance Health Group, Inc. (NASDAQ: LFST) common stock issued in connection with LifeStance Health's June 10, 2021 initial public stock offering (the "IPO"). Captioned Nayani v.

LFST INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against LifeStance Health Group, Inc. and Announces Opportunity for Investors with Substantial Losses to Lead Case

SAN DIEGO--(BUSINESS WIRE)---- $LFST #IPO--LifeStance Health Group, Inc. (LFST) Filed a Misleading Registration Statement with the SEC in Support of the Company's IPO

Shareholder Alert: Robbins LLP Informs Investors of Class Action Against LifeStance Health Group, Inc. (LFST)

NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of LifeStance Health Group, Inc. (NASDAQ: LFST) pursuant and/or traceable to the registration statement and related prospectus (collectively, the “Registration Statement”) issued in connection with LifeStance Health's June 2021 initial public offering (the “IPO”). A class action lawsuit has already been filed. If you wish to

EQUITY ALERT: Rosen Law Firm Encourages LifeStance Health Group, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – LFST

San Diego, California--(Newsfile Corp. - August 12, 2022) - Shareholder rights law firm Johnson Fistel, LLP announces that a class action lawsuit has commenced on behalf of investors of LifeStance Health Group, Inc. (NASDAQ: LFST). The class action is on behalf of shareholders who purchased or otherwise acquired LifeStance Health in or traceable to LifeStance Health June 2021 initial public offering (the "IPO").

LifeStance Health Class Action Complaint Filed: Johnson Fistel, Globally-Recognized Law Firm Encourages Shareholders to Submit Their LifeStance Health Losses

NEW ORLEANS--(BUSINESS WIRE)--Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until October 11, 2022 to file lead plaintiff applications in a securities class action lawsuit against LifeStance Health Group, Inc. (NasdaqGS: LFST), if they purchased or acquired the Company's Class A common stock pursuant and/or traceable to the Company's June 2021 initial public offering (the “IPO”). This action is pen

LIFESTANCE HEALTH SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against LifeStance Health Group, Inc. - LFST

NEW YORK--(BUSINESS WIRE)-- #Action--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against LifeStance Health Group, Inc. (“LifeStance” or the “Company”) (NASDAQ: LFST) in the United States District Court for the Southern District of New York on behalf of all persons and entities who purchased or otherwise acquired LifeStance securities pursuant to the Company's June 11, 2021 IPO (the “Class Period”). Investors ha

LIFESTANCE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against LifeStance Health Group, Inc. and Encourages Investors to Contact the Firm

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired LifeStance Health Group, Inc. (“LifeStance” or the “Company”) (NASDAQ: LFST) common stock pursuant and/or traceable to the Registration Statement and Prospectus issued in connection with LifeStance's June 10, 2021 initial public stock offering (the “IPO”). LifeStance

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of LifeStance Health Group, Inc. (LFST) Investors

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased LifeStance Health Group, Inc. (“LifeStance” or the “Company”) (NASDAQ: LFST) common stock pursuant and/or traceable to the Registration Statement and Prospectus issued in connection with LifeStance's June 10, 2021 initial public stock offering (the “IPO”). LifeStance investors have until October 11, 2022 to file a lead plaintiff motion. Investo

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of LifeStance Health Group, Inc. (LFST) Investors

NEW YORK--(BUSINESS WIRE)---- $LFST #classaction--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of those who acquired LifeStance Health Group, Inc. (“LifeStance” or the “Company”) (NASDAQ: LFST) securities pursuant and/or traceable to the Registration Statement and Prospectus issued in connection with LifeStance's June 10, 2021 initial public stock offering (the “IPO”). Investors have until October 11

Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of LifeStance Health Group, Inc. (LFST) Investors

SAN DIEGO--(BUSINESS WIRE)--The suit alleges defendants issued false statements concerning LifeStance business and prospects, resulting in its stock trading at inflated prices.

LFST INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against LifeStance Health Group, Inc. and Announces Opportunity for Investors with Substantial Losses to Lead Case

LifeStance Health (LFST) delivered earnings and revenue surprises of -58.33% and 1.09%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

LifeStance Health Group (LFST) Reports Q2 Loss, Lags Revenue Estimates

SCOTTSDALE, Ariz., Aug. 09, 2022 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation's largest providers of outpatient mental health care, today announced financial results for the quarter ended June 30, 2022.

LifeStance Reports Second Quarter 2022 Results

SCOTTSDALE, Ariz., July 19, 2022 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation's largest providers of outpatient mental health care, will issue its second quarter earnings release after the market closes on Tuesday, August 9, 2022.

LifeStance to Host Second Quarter 2022 Earnings Conference Call on August 9, 2022

LifeStance Health (LFST) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

LifeStance Health (LFST) Soars 6.2%: Is Further Upside Left in the Stock?

SCOTTSDALE, Ariz. , July 7, 2022 /PRNewswire/ --  LifeStance Health Foundation (the "Foundation"), a 501(c)(3) non-profit organization endowed by LifeStance Health (NASDAQ: LFST), today announced the appointment of its first Executive Director, Gwen Booth, effective July 1, 2022.

Gwen Booth Named Executive Director of LifeStance Health Foundation

SCOTTSDALE, Ariz., June 08, 2022 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation's largest providers of outpatient mental health care, today announced that management will present at the upcoming Goldman Sachs 43rd Annual Global Healthcare Conference, which will be hosted in Rancho Palos Verdes, CA.

LifeStance to Participate in the Goldman Sachs Global Healthcare Conference

Gwen Booth Retiring from COO Role; Appointed as Executive Director, LifeStance Health Foundation SCOTTSDALE, Ariz. , May 23, 2022 /PRNewswire/ --  LifeStance Health  (NASDAQ: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced that its Board of Directors approved the appointment of Danish Qureshi, currently Chief Growth Officer, LifeStance, as the company's next Chief Operating Officer, effective July 1, 2022.

LIFESTANCE HEALTH NAMES DANISH QURESHI AS CHIEF OPERATING OFFICER, EFFECTIVE JULY 1, 2022

SCOTTSDALE, Ariz., May 18, 2022 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation's largest providers of outpatient mental health care, today announced that management will present at the upcoming UBS Global Healthcare Conference, which will be hosted at the Lotte New York Palace.

LifeStance to Participate in the UBS Global Healthcare Conference

LifeStance Health Group, Inc. (NASDAQ:LFST ) Q1 2022 Earnings Conference Call May 9, 2022 4:30 PM ET Company Participants Michael Lester – Chief Executive Officer Michael Bruff – Chief Financial Officer Danish Qureshi – Chief Growth Officer Monica Prokocki – Vice President of Investor Relations Conference Call Participants Ricky Goldwasser – Morgan Stanley Lisa Gill – JPMorgan Chris Neamonitis – Jefferies Kevin Caliendo – UBS Jamie Perse – Goldman Sachs Nicholas Spiekhout – William Blair Gary Taylor – Cowen Operator Good day, and welcome to the LifeStance Health First Quarter 2022 Earnings call. At this time all participants are in listen-only mode.

LifeStance Health Group, Inc. (LFST) CEO Michael Lester on Q1 2022 Results - Earnings Call Transcript

SCOTTSDALE, Ariz., May 09, 2022 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation's largest providers of outpatient mental health care, today announced financial results for the quarter ended March 31, 2022.

LifeStance Reports First Quarter 2022 Results

LifeStance Health Group aims to solve mental issues for its clients. The company has seen a very tough year following the IPO, as the business is really losing quite a bit of money.

LifeStance Health Group: Real Issues

SCOTTSDALE, Ariz., April 18, 2022 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation's largest providers of outpatient mental health care, will issue its first quarter earnings release after the market closes on Monday, May 9, 2022.

LifeStance to Host First Quarter 2022 Earnings Conference Call on May 9, 2022

New Findings Highlight the Growing Youth Mental Health Crisis in America; Half of Parents Believe That Missing Life Milestones Has Negatively Impacted Their Children's Mental Health In Support of Youth and Adolescent Mental Health, LifeStance Health Foundation Awards Grants to American Foundation for Suicide Prevention, Peer Health Exchange and Hillsboro Schools Foundation SCOTTSDALE, Ariz. , March 30, 2022 /PRNewswire/ --  LifeStance Health  (NASDAQ: LFST), one of the nation's largest providers of outpatient mental health care, today released its State of Youth Mental Health Report , a nationwide survey by LifeStance with OnePoll that explores how parents are addressing their children's mental health.

LIFESTANCE SURVEY FINDS THAT 68% OF PARENTS HAVE SEEN THEIR CHILDREN FACE SIGNIFICANT MENTAL AND EMOTIONAL CHALLENGES DURING THE COVID-19 PANDEMIC

LifeStance Health Group, Inc. (LFST) CEO Mike Lester on Q4 2021 Results - Earnings Call Transcript

News for LifeStance Health Group Stock (LFST)